DNA RNA and Cells

10 Aug 2008 Geron Initiates Clinical Trial of GRN163L in Combination with Paclitaxel and Bevacizumab in Patients with Breast Cancer
07 Aug 2008 Genzyme and Isis Begin Second Phase 3 Trial of Mipomersen
06 Aug 2008 Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
06 Aug 2008 Lorus Toxicology Program Supports Novel Route of Administration of the Anticancer Drug LOR-2040 in Bladder Cancer
05 Aug 2008 Argos Therapeutics´ Arcelis™ Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial
31 Jul 2008 Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
31 Jul 2008 Preliminary Cerepro Phase III Results Meet Primary Endpoint
30 Jul 2008 Quark Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in DME
30 Jul 2008 Medgenics Granted Approval to Commence Its Landmark Phase I/II Clinical Study of Epodure to Treat Anemia
26 Jul 2008 GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration to enable the discovery of new medicines
23 Jul 2008 TOPIGEN Pharmaceuticals Completes Enrollment of Phase II Clinical Study of TPI ASM8 in Asthma
23 Jul 2008 ADVEXIN(R) Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population
22 Jul 2008 Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
21 Jul 2008 Cenix BioScience GmbH Signs Research Agreement with Regulus Therapeutics (JOBS) for miRNA-Targeted Drug Discovery
16 Jul 2008 Dendreon Initiates Phase 2 Trial of PROVENGE in Patients with Localized Prostate Cancer Prior to Surgery
16 Jul 2008 Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis
16 Jul 2008 MOLOGEN AG: First patient enrolled in clinical study with cancer therapy MGN1703
08 Jul 2008 BrainStorm Cell Therapeutics Inc. Study Positive for Spinal Cord Injuries
07 Jul 2008 Early findings show promise as AS1411 AML study proceeds to higher-dose stage
03 Jul 2008 VAVELTA(R) Phase II data presented at FACE
02 Jul 2008 MicroIslet Provides Safety and Efficacy Data Update
02 Jul 2008 Titan Pharmaceuticals Announces Spheramine(R) Initial Phase IIb Results
02 Jul 2008 Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
30 Jun 2008 Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
30 Jun 2008 Teva & ANP Announce That Atl/Tv1102, a Novel Drug for The Treatment Of Relapsing Remitting Multiple Sclerosis (Rrms), Demonstrated Significant Reduction In Disease Activity

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up